Sep 16, 2015 7:30 am EDT AntriaBio Announces New Product Candidate, AB301, a Weekly GLP-1 Agonist and Basal Insulin Combination, for Type 2 Diabetes
Jun 8, 2015 7:30 am EDT AntriaBio Announces Promising Preclinical Results for Once-Weekly Basal Insulin AB101
May 11, 2015 8:00 am EDT AntriaBio to Present New Preclinical Data at the American Diabetes Association 75th Scientific Sessions
Jan 8, 2015 7:35 am EST AntriaBio Announces Appointment of Dr. Hoyoung Huh as Chairman of Scientific Advisory Board and Business Development
